Status:
UNKNOWN
Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?
Lead Sponsor:
Modum Bad
Collaborating Sponsors:
University of Oslo
Conditions:
Depressive Symptoms
Metacognitive Variables
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to identify symptom-level intervention targets for depression related to the COVID-19 outbreak. First, we will assess centrality indices of the network of depression symptoms p...
Detailed Description
Hypotheses (Hs) H1: In the cross-sectional depression-metacognitive network at T1, the symptoms depressed mood, little interest/pleasure, and self-blame and the metacognitive coping variables ruminati...
Eligibility Criteria
Inclusion
- all adults residing in Norway during the government-initiated interventions for the COVID-19 pandemia
Exclusion
- none
Key Trial Info
Start Date :
June 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 13 2020
Estimated Enrollment :
10084 Patients enrolled
Trial Details
Trial ID
NCT04444713
Start Date
June 22 2020
End Date
July 13 2020
Last Update
June 23 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.